Introgression decreases allelic shuffling. by Enrique J. Schwarzkopf (6579275)

Significant Decrease in Vessel Count of Trade Vessels in (a) Bosporus Strait and (b) Bab el-Mandeb Strait. by Cherryl Chico (20978829)

Effects of GJE extract treatment decreased serum ALT and AST levels. by Natnicha Suttawong (22367172)

TH5487 decreases RSV replication in lungs. by Lang Pan (5145221)

Lymphocytes decreased in mouse pneumonia model. by Qi Xu (134661)

HSP90 inhibition by RGRN-305 and 17-AAG decreased proinflammatory protein secretion. by Hakim Ben Abdallah (14578241)

Effects of GJE extract treatment decreased accumulation of Col1a1. by Natnicha Suttawong (22367172)

Tetrandrine decreases Mtb antigen presentation. by Elham Karamooz (2584474)

Effects of GJE extract treatment decreased expression of NF-kB p65. by Natnicha Suttawong (22367172)

Line graph showing the increase or decrease in the average number of bee swarms caught over the past three years (Mean  by Beatrice T. Nganso (4114768)

The reduced virulence of Δalta1 mutants is not primarily due to a decrease in growth. by Shuhuan Zhang (748003)

CKO mice display decreased skin barrier function and perturbed homeostasis. by Kevin J. Mills (9270966)

GLS inhibition decreases IL-1β secretion <i>in vitro</i>. by Bárbara Ponzilacqua-Silva (17002156)

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

TH5487 decreases RSV-induced release of lactose dehydrogenase (LDH). by Lang Pan (5145221)

A summary of the included study characteristics. by Zahra Tajik (20752452)

Subjects:

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”

HSP90 inhibition by RGRN-305 decreased the gene expression of proinflammatory cytokines induced by SARS-CoV-2 S protein. by Hakim Ben Abdallah (14578241)